pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
  • phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06284642: Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

    Sponsor: Second Affiliated Hospital of Nanchang University. Phase: PHASE4. Conditions: Aneurysmal Subarachnoid Hemorrhage

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05711186: Structured Shared Decision Making for Patients Undergoing SAVR or TAVR

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: Aortic Valve Stenosis, Symptomatic Aortic Stenosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07104383: VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

    Sponsor: Viking Therapeutics, Inc.. Phase: PHASE3. Conditions: Weight Loss

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06486441: Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

    Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06156254: Community Care Intervention to Decrease COVID-19 Vaccination Inequities

    Sponsor: RAND. Phase: NA. Conditions: COVID-19 Vaccination

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06658405: Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions

    Sponsor: Centre Oscar Lambret. Phase: PHASE2. Conditions: Cervical Lesion

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07597694: Verbal Intent and Gaze Cues on Action Prediction in ASD

    Sponsor: University of Electronic Science and Technology of China. Phase: . Conditions: Autism Spectrum Disorder (ASD), Intellectual Disability

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06747156: A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases

    Sponsor: Ruijin Hospital. Phase: EARLY_PHASE1. Conditions: Autoimmune Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06739122: A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Type 2 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04545151: Verapamil SR in Adults With Type 1 Diabetes

    Sponsor: Medical University of Graz. Phase: PHASE2. Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02192151: Study of PHN131 in Healthy Volunteers

    Sponsor: PhytoHealth Corporation. Phase: . Conditions: Analgesia Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06464029: Pathways Mediating Impaired Postural Control in Parkinson's Disease

    Sponsor: University of Minnesota. Phase: . Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07601529: Comparison of Anterior Sciatic Nerve Block and Adductor Magnus Muscle Plane Block for Anterior Cruciate Ligament Surgery

    Sponsor: Ataturk University. Phase: NA. Conditions: ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06743529: Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia

    Sponsor: Nantes University Hospital. Phase: NA. Conditions: Ventilator-Associated Pneumonia (VAP)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06737731: A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors

    Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.. Phase: PHASE1. Conditions: Malignant Solid Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07451431: Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain

    Sponsor: Bangladesh Medical University. Phase: PHASE4. Conditions: Diabetic Peripheral Neuropathic Pain (DPNP)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06033131: PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

    Sponsor: Lina Bergman. Phase: PHASE3. Conditions: Preeclampsia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07222202: Evaluation of Flexible Conductive Hearing Aids

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Conductive Hearing Loss

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07280637: Regenarative Treatment of Periocular Wrinkles With PDRN

    Sponsor: University of Taubate. Phase: NA. Conditions: Skin Wrinklings

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07145645: Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children

    Sponsor: University of Calgary. Phase: PHASE3. Conditions: Musculoskeletal Injury, Pediatrics, Sprain and Strain of Ankle, Sprain Knee, Strain Knee

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07220772: A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE3. Conditions: Monogenic Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07146295: Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

    Sponsor: Isabelle Henskens. Phase: NA. Conditions: Breast Cancer, Sentinel Lymph Node Biopsy (SLNB), Sentinel Lymph Node Detection, Sentinel Lymph Node, Lymphatic Metastasis, Fluorescence Imaging, Indocyanine Green (ICG), Radioisotopes, Lymph Node Mapping

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07668739: Efficacy of Verciguat in TR and RV Failure

    Sponsor: Daejeon St. Mary's hospital. Phase: PHASE4. Conditions: HFrEF, Tricuspid Regurgitation (TR)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07427875: Breathing Exercises for Pain and Anxiety During Arteriovenous Fistula Cannulation

    Sponsor: Emine Kaplan Serin. Phase: NA. Conditions: Hemodialysis, Arteriovenous Fistula Cannulation, Breathing Exercises, Pain, Anxiety, Comfort

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06066957: Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

    Sponsor: University of Pennsylvania. Phase: PHASE2. Conditions: Cytomegalovirus Infections, Transplant-Related Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07425275: Integrated Oral Care Intervention for Xerostomia in Diabetes Patients

    Sponsor: Khyber Medical University Peshawar. Phase: NA. Conditions: Diabetes Mellitus, Diabetic Neuropathies

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07429357: The REWIRE Behaviour Study

    Sponsor: Gary Goldfield. Phase: NA. Conditions: Anxiety Depression, Social Media

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02650401: Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

    Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Solid Tumors, CNS Tumors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07403981: Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients

    Sponsor: Stanford University. Phase: NA. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05357781: Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Hypogammaglobulinemia, Multiple Sclerosis, Fatigue

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06895681: UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

    Sponsor: University of California, San Francisco. Phase: . Conditions: Solid Tumor, Solid Tumor, Adult, Somatic Mutation, Solid Tumor, Unspecified, Adult, Hereditary Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07396519: Bioequivalence Study of Dronedarone Hydrochloride Tablets

    Sponsor: Shandong New Time Pharmaceutical Co., LTD. Phase: NA. Conditions: Atrial Fibrillation (AF)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04404530: Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)

    Sponsor: Emory University. Phase: . Conditions: Phenylketonurias

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07598630: SHAPE Versus Milligan-Morgan Hemorrhoidectomy for Hemorrhoidal Disease

    Sponsor: Cairo University. Phase: NA. Conditions: Hemorrhoid

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07420530: Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Motion

    Sponsor: Indiana University. Phase: EARLY_PHASE1. Conditions: Exercise-Induced Vocal Cord Dysfunction, Paradoxical Vocal Fold Motion, Vocal Cord Dysfunction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02818465: Role of the Interaction Between Advanced Glycation End Products and Their Receptor RAGE in the Development and the Progression of the Uremic Vasculopathy of Hemodialyzed Patients

    Sponsor: CHU de Reims. Phase: NA. Conditions: Hemodialyzed Patients

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07469865: Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)

    Sponsor: University Hospital, Ghent. Phase: NA. Conditions: Dry Eye Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02553967: Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)

    Sponsor: Centre Oscar Lambret. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT02537067: Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle

    Sponsor: Cellontech Co., Ltd.. Phase: PHASE3. Conditions: Defect of Articular Cartilage, Degenerative Joint Disease of Ankle and/or Foot, Ankle (Ligaments); Instability, Familial

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07405567: Ultrasound Evaluation of Respiratory Muscles During Mechanical Ventilation Weaning in ICU Patients

    Sponsor: Bursa Sevket Yilmaz Training and Research Hospital. Phase: . Conditions: Pneumonia, Invasive Mechanical Ventilation, Weaning From Mechanical Ventilation in Care Unit, Respiratory Muscle Dysfunction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05482867: Exploratory Open Label Study for Development of a Method To Detect Dendritic Cells

    Sponsor: MindImmune Therapeutics, Inc.. Phase: . Conditions: Probable Alzheimer's Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06572267: Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease

    Sponsor: Xijing Hospital. Phase: PHASE2. Conditions: Coronary Artery Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07596407: Acute Kidney Injury : Long-term Renal and Cardiovascular Prognosis and Biomarker-based Risk Assessment

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Renal Injury, Acute

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07222007: Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients

    Sponsor: Zeliha Alicikus. Phase: . Conditions: Critically Ill, Intubation Complication, Oxygenation, Airway Management, Propofol, Ketamine

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06390592: Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe Harmony

    Sponsor: Fresenius Medical Care Deutschland GmbH. Phase: NA. Conditions: Renal Failure, Chronic Kidney Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02793492: Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery

    Sponsor: Terumo Medical Corporation. Phase: NA. Conditions: Iliac Artery Stenosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07656792: A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06239792: Sleep Promotion Program Primary Care (SPP PC) Open Trial

    Sponsor: University of Pittsburgh. Phase: NA. Conditions: Sleep, Sleep Disturbance, Insufficient Sleep

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07586592: Comparison of Age-Based Formula and Ultrasound-Guided Subglottic Diameter Measurement for Endotracheal Tube Sizing

    Sponsor: Ain Shams University. Phase: NA. Conditions: Endotracheal Tube Wrongly Placed During Anesthetic Procedure

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04491292: Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

    Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: COVID-19 Infection

    full page →ctgov ↗
    ← prev
    page 83 of 104
    next →